Name | 2-Hydroxy-3-nitrobiphenyl-3-carboxylic acid |
---|---|
Synonyms |
2'-Hydroxy-3'-nitrobiphenyl-3-carboxylic acid
[1,1'-Biphenyl]-3-carboxylic acid,2'-hydroxy-3'-nitro 2-Hydroxy-3-nitrobiphenyl-3-carboxylic acid 2'-Hydroxy-3'-nitro-3-biphenylcarboxylic acid 3-(2-hydroxy-3-nitrophenyl)benzoic acid [1,1'-Biphenyl]-3-carboxylic acid, 2'-hydroxy-3'-nitro- 2'-Hydroxy-3'-nitro-[1,1'-biphenyl]-3-carboxylic acid Eltrombopag olamine Intermediate 2 |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 452.2±40.0 °C at 760 mmHg |
Molecular Formula | C13H9NO5 |
Molecular Weight | 259.214 |
Flash Point | 193.8±15.8 °C |
Exact Mass | 259.048065 |
PSA | 103.35000 |
LogP | 2.83 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.669 |
~% 376591-95-6 |
Literature: LIGAND PHARMACEUTICALS, INC. Patent: WO2006/47344 A1, 2006 ; Location in patent: Page/Page column 45; 155 ; |
~76% 376591-95-6 |
Literature: Erickson-Miller, Connie J; Eppley, Daniel F.; Jenkins, Julian; Luengo, Juan I.; Liu, Nannan; Price, Alan T.; Shaw, Anthony N.; Visonneau, Sophie; Wiggall, Kenneth Patent: US2004/19190 A1, 2004 ; Location in patent: Page 18 ; |
Precursor 2 | |
---|---|
DownStream 1 | |